Home › Products › Hematology › Defrijet FCT 360mg Tablet

Defrijet FCT 360mg Tablet

Salt Composition: DEFERASIROX

₹561.00₹637.50

Inclusive of all taxes

Categories: Hematology

Conditions: Others

Product Introduction

Defrijet FCT 360 mg Tablet contains deferasirox, an iron-chelating agent used to manage chronic iron overload in patients who require frequent blood transfusions. It is commonly prescribed for individuals with transfusion-dependent anemias such as beta-thalassemia and certain myelodysplastic syndromes, where repeated transfusions can lead to excessive iron accumulation in the body. By removing excess iron, the medication helps reduce the risk of iron-related damage to vital organs.

The dosage of Defrijet FCT 360 mg should be taken exactly as directed by the treating physician, based on the patient's medical condition and response to treatment. Patients with existing kidney or liver disorders should use this medicine cautiously, as it may affect the function of these organs. Regular monitoring of kidney and liver function may be required throughout therapy to detect any potential complications at an early stage.

Manufactured by Sun Pharma, Defrijet FCT 360 mg is widely used for the long-term management of iron overload. It works by binding to excess iron in the bloodstream to form a stable complex that is eliminated from the body, thereby lowering iron levels and helping prevent organ damage associated with iron accumulation.

The safety of this medicine during pregnancy has not been fully established; therefore, its use should only be considered if the potential benefits outweigh the possible risks, as determined by the healthcare provider. Patients should store the tablets according to the recommended storage instructions to maintain their effectiveness. If necessary, the doctor may also suggest a suitable generic alternative based on the patient's clinical needs and product availability.

Uses

Defrijet FCT 360 uses are Iron overload

How it works

Defrijet FCT 360mg Tablet works by binding to excess iron in the body and helping to remove it through urine and feces. It forms a stable chelate complex with iron, which prevents the iron from causing further damage to organs and tissues.

How to Use

Take the Defrijet FCT 360mg Tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side Effects

Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them. Defrijet FCT 360 side effects are Severe Liver problems Kidney problems (decreased urine output) Pancreatitis Severe allergic reaction Flu-like symptoms (high fever) Dizziness, headache, difficulty thinking, loss of vision (brain problems) Vomiting or black, tarry stools Tears in the stomach wall Common Nausea and vomiting, indigestion, constipation Stomach ache Disturbance in kidney function tests Disturbance in liver function tests Headache and drowsiness

Expert Tips

If you are taking the dispersible tablet form, dissolve it in water or another liquid and drink immediately. Do not stop taking this drug without consulting your physician. Iron overload is a chronic condition that requires ongoing management, and stopping medication suddenly may cause adverse effects. Defrijet FCT 360mg Tablet can be taken with or without food. If you experience stomach upset, take it with food to help reduce gastrointestinal side effects.

References

  1. Novartis Pharmaceuticals UK Ltd, European Medicine Consortium (EMC), [Revised on June 2022], Available at: https://www.medicines.org.uk/emc/files/pil.4329.pdf [Accessed on 5th June 2023].
  2. Novartis Pharmaceuticals, US Food & Drug Administration [Revised on Jul 2020] [Accessed on 5th June 2023], https://www.novartis.com/us-en/sites/novartis_us/files/jadenu.pdf
  3. Goodman & Gilman's Pharmacological Basis of Therapeutics, Environmental Toxicology: Carcinogens and Heavy Metals, 13th Edition, 2018, 1297-1315.

Safety Advice

Pregnancy: unsafe Defrijet FCT 360mg Tablet should not be taken unless it is necessary during pregnancy. Report to your doctor if you are pregnant, suspecting, or planning for the pregnancy before starting the treatment.

Lungs: Consult your doctor It is unknown whether Defrijet FCT 360mg Tablet is safe for patients with lung problems. Contact your doctor if you experience any lung-related symptoms.

Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Defrijet FCT 360mg Tablet because it may harm your baby. Do not breastfeed during the treatment.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS